coplug
    Back to PCN explorer
    PCN reports · Core20PLUS5

    Whitstable PCN, Canterbury · Health Inequalities Profile

    PCN U32995 · NHS Kent and Medway Integrated Care Board · 1 GP practice

    Read the report

    This report is generated by Coplug's Healthcare Agent. Log in to ask further questions of it, add the spatial context, or create new enquiries to better understand and improve your Neighbourhood's Health

    01 / 15

    Board summary

    Key figures

    45,518

    Registered population

    55.6% aged 18–64

    27.6%

    Aged 65+

    ICB 19.9% · England 17.9%

    6.7%

    Ethnic minority (non-White)

    2.5% Asian · England 9.6%

    10.0%

    In IMD quintile 1

    ICB 17.1% · England 21.0%

    ~3,586

    Core20 residents (est.)

    Resident basis; registered basis ~4,552 · see page 3

    7,918

    Hypertension register

    +2.83% in 3 yrs · England +5.60%

    422

    SMI register

    20% of Canterbury's

    1,143

    COPD register

    Reviews -4.32% in 3 yrs

    Forecast to 2030

    9,240

    Hypertension patients, 2030

    +1,322 on today

    71.6%

    QRISK ≥20% on statins, 2030

    +5.20pp over 3 yrs

    7.5%

    Cancer prevalence, 2030

    England 4.5%

    Three things the board should see

    66.0%
    Heart failure reviews fell below England.

    Heart failure reviews stand at 66.0% versus 78.5% in England after falling 10.2% over three years (England +8.7%), which may reflect recall pressure.

    57.1%
    Asthma reviews and youth smoking checks lag.

    Asthma reviews reached 57.1% (England 65.7%), leaving about 1,400 of 3,343 register patients unreviewed, alongside 61.8% youth second-hand smoke recording (England 78.8%).

    80.7%
    Breast and cervical screening exceed national rates.

    Breast screening reached 80.7% (England 69.9%) after a +13.4% 3-year change (England +8.4%), while cervical screening in ages 25-49 reached 77.3% (England 66.8%).

    Sources & context

    PCN and practice-level primary care data; ICB and provider context on page 8

    Powered by Coplug · Page 1 of 15
    02 / 15

    Population, age and ethnicity

    Older age profile dominates with 27.6% aged 65+ against 17.9% across England

    Whitstable PCN comprises 45,518 registered patients. Among registered patients, 27.6% (12,583 patients) are aged 65+, exceeding Canterbury (18.4%), NHS Kent and Medway ICB (19.9%), and England (17.9%), while ages 18–64 represent 55.6% and ages 0–17 represent 16.8%. Area Census data shows 93.3% identifying as White (Canterbury 89.2%, ICB 88.6%, England 81.1%) and 2.5% as Asian / Asian British (Canterbury 4.0%, ICB 4.7%, England 9.6%). Projected population growth to 2030 is 6.3% (Canterbury 7.0%, ICB 6.0%, England 2.3%), using unverified forecast methodology.

    Age profile

    0–1716.8%
    18–6455.6%
    65+27.6%

    65+: ICB 19.9%, England 17.9%

    Ethnicity

    White93.3%
    Asian2.5%
    Mixed1.9%
    Black1.6%
    Other0.8%

    Older people · falls rows are Canterbury local-authority (LA) data, not PCN

    MeasureLocalSouth EastEnglandPeriod
    Falls admissions, 65+, per 100,000 (Canterbury LA)1,5772,0181,9582024/25
    Diabetes with frailty: HbA1c ≤75 mmol/mol (PCN)84.2%82.2%81.9%2024/25
    Diabetes without frailty: HbA1c ≤58 mmol/mol (PCN)57.9%57.8%57.4%2024/25
    Falls admissions, 65 to 79, per 100,000 (Canterbury LA)6829819552024/25
    Falls deaths, all ages, per 100,000 (Canterbury LA)18.214.014.82022‑24
    Sources & context

    Census 2021; Fingertips falls and diabetes. Falls are local-authority data. Ethnic minority = 100% minus White

    Powered by Coplug · Page 2 of 15
    03 / 15

    Deprivation and Core20

    Core20 share is 10.0% versus 21.0% in England, covering six decile two LSOAs

    Whitstable PCN has an average IMD decile of 6.8, reflecting lower deprivation than Canterbury (5.7), NHS Kent and Medway ICB (5.4), and England (5.5). Its Core20 share is 10.0% (Canterbury 19.3%, ICB 17.1%, England 21.0%). However, Core20 headcounts diverge between bases: 3,586 associated residents live in 6 national decile 2 LSOAs, whereas applying the 10.0% registered share to the single practice (Whitstable Medical Practice, list 45,518) produces 4,552 patients. The PCN should reconcile resident LSOA mapping against practice postcode registers before committing outreach resources.

    % of patients in IMD quintile 1, by practice

    Dashed line: England 21.0% · right column: Core20 patients, registered basis

    Whitstable10.0% · 4,552 patients
    Sources & context

    Deprivation: Index of Multiple Deprivation, applied to registered patients

    Powered by Coplug · Page 3 of 15
    04 / 15

    PLUS groups and inclusion health

    PLUS groups and inclusion health

    422

    SMI register

    0.95% recorded prevalence

    231

    Learning disability register

    0.52% recorded prevalence

    31

    Care homes, 1,120 beds

    In the PCN catchment

    9.3%

    Provide unpaid care

    Canterbury, Census 2021

    The PCN records 231 learning disability patients (0.5% vs 0.6% in Canterbury, NHS Kent and Medway ICB, and England) and 422 severe mental illness patients (0.9% vs Canterbury 1.1%, ICB 0.9%, England 1.0%). Catchment services include 31 care homes with 1,120 beds, though bed capacity does not establish registered patient occupancy.

    Severe mental illness: physical health checks

    Among 422 severe mental illness patients, blood pressure checks reached 84.6% (England 83.4%), while BMI recording was 80.8% (England 82.1%) and alcohol recording was 71.9% (England 81.8%). Separate check elements show uneven physical health monitoring across the cohort.

    Sources & context

    QOF registers; Census 2021 carers; care homes and homelessness as supplied. Carers and homelessness are local-authority data

    Powered by Coplug · Page 4 of 15
    05 / 15

    Clinical focus: hypertension and lipids

    Clinical focus: hypertension and lipids

    7,918

    Hypertension register

    +2.83%

    Register growth, 3 yrs

    Canterbury +3.48% · England +5.60%

    −0.27pp

    BP control, under 80

    ≤140/90 · −3.98pp aged 80+

    +1,322

    More patients by 2030

    Forecast 9,240 (18.76%)

    Hypertension case-finding and control

    Hypertension recorded prevalence is 17.7% (7,918 patients), above England (15.2%), Canterbury (15.6%) and NHS Kent and Medway ICB (16.2%), although crude prevalence is not age-adjusted. Register growth was +2.8% over three years (England +5.6%). Blood pressure recording reached 86.2%, trailing England (90.0%) and the ICB (87.3%), falling 0.8% over three years while England rose +3.6%. Furthermore, blood pressure control in patients aged 80 and over stands at 75.4%, below England (81.2%), Canterbury (78.3%) and the ICB (78.3%), after falling 5.0% over three years (England +2.2%). Lower recording and control rates than England could reflect monitoring gaps in older cohorts, which structured reviews could test.

    Lipids and statins

    For patients with QRISK ≥ 20%, lipid-lowering therapy uptake is 59.6%, trailing England (63.6%) despite growing +9.6% over three years (England +6.2%). CKD treatment reaches 72.3% (England 70.3%). Lower uptake than England could reflect primary prevention review timing.

    MeasureItemsCost / itemICBEnglandAnnual spend
    Lipid-modifying, 202675,301£2.40£1.90£1.86£180,722
    Cardiovascular (all), 2025102,229£4.04£3.57£3.33£413,005

    In 2026, lipid-regulating drug prescribing totaled 75,301 items at £2.40 per item (£180,722 spend), above Canterbury (£2.23), NHS Kent and Medway ICB (£1.90) and England (£1.86), spending £40,663 more than at England's unit cost. Higher unit spend may reflect formulary choices rather than inefficiency.

    Sources & context

    QOF hypertension register and BP control indicators; prescribing items and cost as supplied

    Powered by Coplug · Page 5 of 15
    06 / 15

    Clinical focus: respiratory, cancer register and children

    Clinical focus: respiratory, cancer register and children

    Respiratory

    +7.48%

    Asthma reviews, PCN 3-yr % change

    +4.44%

    Asthma reviews, England 3-yr % change

    +5.98%

    Asthma prevalence, PCN 3-yr % change

    Asthma prevalence is 7.8% (3,343 patients; England 6.6%) and COPD prevalence is 2.6% (1,143 patients; England 1.9%). Annual reviews trail England for asthma at 57.1% (England 65.7%, leaving about 1,400 unreviewed) and COPD at 69.1% (England 76.4%), where reviews fell 4.3% over three years (England +2.8%). Second-hand smoke recording for ages 6–19 is 61.8% (England 78.8%), alongside 1,689 asthma items prescribed per 1,000 youth (England 1,488). Lower review rates than England could reflect review capacity across respiratory clinics.

    Cancer register and children's immunisation

    Cancer prevalence is 6.5% (2,895 patients; England 3.8%). In childhood immunisations for Q1 2025/26, MMR dose 1 coverage reaches 97.0% by age 5 (England 91.7%), but MMR dose 2 is 7.4 pp lower at 89.6% (England 82.8%), standing 5.4 pp below the 95.0% target in cohort denominator 67. The drop between doses suggests attrition before primary school entry.

    Dashed line: 95% national coverage target · solid tick: England

    6-in-1 at 12 months94.2%

    England 91.0%

    6-in-1 complete primary course at 24 months96.7%

    England 92.2%

    MMR dose 1 at 24 months94.6%

    England 88.3%

    MMR dose 2 at age 589.6%

    England 82.8%

    4-in-1 pre-school booster at age 589.6%

    England 80.9%

    Sources & context

    QOF registers and review indicators; childhood immunisation coverage as supplied

    Powered by Coplug · Page 6 of 15
    07 / 15

    Early cancer diagnosis

    Early cancer diagnosis

    55.6%

    Kent and Medway ICB, stage 1–2

    55.3%

    England, 2022

    75%

    National ambition by 2028

    ~1,630

    Extra early-stage cases a year to reach the ambition

    Stage 1–2 share by cancer type, 2022Kent and Medway ICBEnglandNo usable stageStaged cancers
    Breast82.1%85.4%23%1,509
    Prostate54.4%53.2%37%1,435
    Lung29.4%33.8%21%1,109
    Bowel48.2%47.0%29%1,013
    Skin cancer87.5%87.8%23%562

    Across NHS Kent and Medway ICB in 2022, 55.6% of cancers with a known stage were diagnosed at stage 1 or 2 (4,661 of 8,384), in line with England (55.3%) but 19.4 pp below the 75.0% national ambition. Known stage was recorded for 63.6% of registered cancers (8,384 of 13,189; England 67.0%). Reaching the 75.0% ambition would require 1,627 additional early-stage diagnoses yearly across the ICB. These figures describe ICB-level delivery, not PCN performance. At Whitstable PCN, 2,895 patients are on the cancer register (6.5%), with three-year register growth of +7.8% (England +9.0%).

    Sources & context

    Stage at diagnosis: National Disease Registration Service

    Powered by Coplug · Page 7 of 15
    08 / 15

    Cancer waits, diagnostics and community services

    Cancer waits, diagnostics and community services

    Cancer waits and diagnostics, Jul 2026 (provisional)

    In July 2026 (provisional), East Kent Hospitals University NHS Foundation Trust achieved 70.0% on the 62-day cancer referral to treatment standard (15.0 pp below the 85.0% standard; NHS Kent and Medway Integrated Care Board 75.9%, England 71.2%) and 71.3% on the 28-day faster diagnosis standard (standard 75.0%). For diagnostics in July 2026, 48.4% of patients waited 6+ weeks at East Kent Hospitals (Medway NHS Foundation Trust 14.2%, England 23.1%), including non-obstetric ultrasound (63.0%), MRI (47.6%), and colonoscopy (9.6%). These provider figures describe secondary care activity, not PCN performance.

    Pathways within standard (%)East KentMid and South EssexMedwayKent and Medway ICBEngland
    28-day faster diagnosis (75%)71.2867.4577.7776.7879.32
    31-day treatment (96%)96.6781.8899.6295.8492.50
    62-day referral to treatment (85%)70.0150.2581.6475.9371.16
    Diagnostic waits over 6 weeks (%)East KentMid and South EssexMedwayEngland
    MRI47.5823.350.6821.40
    CT37.456.070.009.92
    Echocardiography14.1765.0536.6228.48
    Colonoscopy9.5864.091.8830.83
    Gastroscopy22.1659.763.3229.02
    All 15 DM01 tests48.3841.5414.2023.14
    Community services activityKent residentsKent and Medway ICB
    Care contacts210,170254,055
    Referrals59,36068,085
    Patients with a contact60,60572,060

    Community services (residents of Kent), Jun 2026 (provisional). In June 2026 (provisional), Kent residents accounted for 210,170 community care contacts and 60,605 individual patients, within 254,055 contacts across NHS Kent and Medway Integrated Care Board. Adults aged 65+ represented 65.8% of Kent contacts (138,250). New community referrals reached 59,360 in Kent (ICB 68,085). These community statistics describe local authority and ICB activity, not PCN performance.

    Sources & context

    Waits and diagnostics: NHS England monthly statistics · ICB and provider data, not PCN

    Powered by Coplug · Page 8 of 15
    09 / 15

    Practice variation and patient experience

    Overall QOF achievement reached 97.1% and patient experience 86.4%, both exceeding England

    In 2025/26, Whitstable Medical Practice achieved 97.1% overall QOF points (England 92.5%) and 100.0% in the clinical domain (England 97.1%). Personalised care adjustments were 9.2% overall (England 10.0%) and 3.8% in vaccination and immunisation (England 4.2%), where points reached 74.7% (England 55.2%). Recorded achievement exceeds England across overall, clinical, and vaccination domains.

    GP Patient Survey by practice

    PracticeResponses% in IMD Q1Phone easyRequest led to apptOverall good
    Whitstable18610.070.2%77.4%86.4%
    England—~2156.9%71.6%76.7%
    Sources & context

    QOF achievement; GP Patient Survey, practice-level results

    Powered by Coplug · Page 9 of 15
    11 / 15

    What the data can't tell us: gaps and local assets

    What the data can't tell us: gaps and local assets

    Local assets and voluntary sectorPCNCanterburyAssetPCNCanterbury
    Care homes (catchment)31 (1,120 beds)n/aSchools (catchment)45n/a
    Children's centres48Places of worship57103
    Libraries22Day centres (VCS)14
    Children and young people (VCS)11Carers support groups (VCS)14
    Primary schools (LA maintained)1219Primary academies513
    Special schools13

    0 = the source returned zero. n/a = not held at this level. No data = no value returned; this does not mean zero.

    Sources & context

    Gaps are modelled estimates against benchmark rates; local assets as supplied

    Powered by Coplug · Page 11 of 15
    12 / 15

    Options for the PCN

    Options for the PCN

    Each option in full

    Option 1

    Structured asthma and youth smoking recall

    Annual asthma reviews reached 57.1% of 3,343 patients versus 65.7% in England (8.6 pp below; about 1,400 unreviewed), with youth smoke recording at 61.8% (England 78.8%). For discussion: Whitstable Medical Practice could run structured recall using a review template prompting second-hand smoke recording for ages 6-19 and offering after-school slots. Moderate effort to run.

    Evidence base: the annual asthma review is the process gap between the register and outcomes.

    Policy anchor: Core20PLUS5 chronic respiratory disease priority.

    Option 2

    Pre-school MMR2 and booster recall

    In Q1 2025/26 (cohort 67), age-5 coverage fell 7.4 pp from MMR1 (97.0%) to MMR2 (89.6%), leaving MMR2 and 4-in-1 (89.6%) 5.4 pp below the 95.0% target. Low cost, quick to run.

    Evidence base: coverage against the 95% target is the direct measure of programme delivery and catch-up need; where coverage clusters low, that decides whether catch-up is organised at practice, PCN, school or outreach level.

    Policy anchor: 10 Year Health Plan, shift from sickness to prevention.

    Option 3

    Learning disability register validation

    Recorded learning disability prevalence is 0.5% (231 of 45,518 patients) versus 0.6% in Canterbury, the ICB, and England, giving a modelled gap of +32 to +37 patients. For discussion: Whitstable Medical Practice could cross-check clinical records for unlinked diagnostic codes and review transition records with social care where sharing exists. Low cost, quick to run.

    Evidence base: the register is the cohort for the annual health check and LeDeR learning; people with a learning disability die on average 20 years earlier and are a Core20PLUS5 PLUS group.

    Policy anchor: annual health checks for 75% of people aged 14+ on the register (Network Contract DES); Oliver McGowan mandatory training.

    Sources & context

    Options are the profile's; evidence base from Coplug's indicator catalogue

    Powered by Coplug · Page 12 of 15
    13 / 15

    Provenance and audit trail

    Provenance and audit trail

    Figures are the profile's, drawn from Coplug indicator tables: census, deprivation and QOF measures, MHCLG, Rough sleeping snapshot in England: autumn 2025, OHID, Fingertips diabetes by frailty status: HbA1c control (93712, 93713) and OHID, Fingertips falls: emergency admissions, 65+ and 65 to 79 (22401, 22402), accidental-fall deaths (94002). Every recommended action and option is the profile's own; the evidence-base statements that support them — what each register is the cohort for, and the national policy it serves — are quoted from Coplug's indicator catalogue. No recommendation in this report is authored outside the profile and that catalogue. ICB- and provider-level data (page 8) describes the system the PCN sits in and is not read as PCN performance.

    RecommendationIndicator(s)Policy anchorData level
    Core20 list reconciliation (p3)Core20 cohort (IMD quintile 1)Core20PLUS5 · 10YHP equity testPCN
    SMI physical health check recall (p4)SMI register with a BMI recorded in the last 12 monthsMHIS · From Harm to HopePCN
    Older hypertension blood pressure review (p5)Last BP reading of patients (80+ yrs with hypertension) in the last 12 months is <= 150/90 mmHg (denominator incl. PCAs)Core20PLUS5 CVD · CVDPREVENT 2029PCN
    Pre-school booster recall (p6)MMR dose 2 coverage at age 510YHP sickness to prevention · 95% targetPCN
    Cancer safety-netting review (p7)Cancer: QOF prevalenceCore20PLUS5, 75% stage 1–2 by 2028PCN
    Option 1 · Structured asthma and youth smoking recall (p12)Asthma register · Patients with Asthma: review in the last 12 months (denominator incl. PCAs) · Patients with Asthma (6-19 yrs): Second-hand smoking status recorded in the last 12 months (denominator incl. PCAs)Core20PLUS5 respiratoryPCN
    Option 2 · Pre-school MMR2 and booster recall (p12)MMR dose 1 coverage at age 5 · MMR dose 2 coverage at age 5 · 4-in-1 pre-school booster (DTaP/IPV) coverage at age 510YHP sickness to prevention · 95% targetPCN
    Option 3 · Learning disability register validation (p12)Learning disability register · Learning disability: QOF prevalence · Registered population75% annual health checks (Network Contract DES) · Oliver McGowanPCN
    Sources & context

    Re-run this profile in 12 months to see whether the gaps have narrowed

    Powered by Coplug · Page 13 of 15
    14 / 15

    Data sources

    Data sources

    Every figure in this profile comes from a dataset below, at the level and period stated. Nothing published above PCN level is read as PCN performance.

    DatasetLevelPeriodUsed for
    Coplug indicator tables: census, deprivation and QOF measuresPCN & Practice2023 to 2025, projected to 2030; 2023 to 2024Pages 1, 2, 3, 4, 5, 6, 7, 8, 10, 12
    MHCLG, Rough sleeping snapshot in England: autumn 2025Local authorityAutumn 2025Pages 2, 4
    OHID, Fingertips diabetes by frailty status: HbA1c control (93712, 93713)PCN2024/25Pages 2, 4
    OHID, Fingertips falls: emergency admissions, 65+ and 65 to 79 (22401, 22402), accidental-fall deaths (94002)Local authority2024/25; 2022-24Pages 2, 4
    ONS, Census 2021 TS039: provision of unpaid care (age-standardised)Local authorityCensus 2021Pages 2, 4
    QOF registers, prevalence and care processes (Coplug indicator tables)Practice2023 to 2025, projected to 2030Pages 4, 5, 6, 7, 8, 10
    UKHSA, COVER supplementary GP data, childhood immunisation coverage, Q1 2025/26PCN & PracticeQ1 2025/26Pages 4, 6
    UKHSA, Seasonal influenza vaccine uptake in GP patients, 2025 to 2026ICB2025/26 season to 28 Feb 2026Pages 4, 6
    NHS England, Cancer Waiting Times: July 2026 monthly time series with revisionsICB & ProviderJul 2026 (provisional)Pages 7, 8
    NHS England, Community Services Statistics (CSDS): June 2026 provisional experimental dataICB & Local authorityJun 2026 (provisional)Pages 7, 8
    NHS England, Monthly Diagnostics Waiting Times and Activity (DM01): provider by test, July 2026ProviderJul 2026Pages 7, 8
    National Disease Registration Service, Stage at diagnosis by cancer site in England, 2013 to 2022ICB2022Pages 7, 8
    NHS England / Ipsos, GP Patient Survey 2026: practice results (weighted)PracticeSurvey Jan-Apr 2026Page 9
    NHS England, Quality and Outcomes Framework 2025-26: achievement by practice and domainPractice2025/26Page 9
    NHS England, Quality and Outcomes Framework 2025-26: personalised care adjustments by practice and domainPractice2025/26Page 9
    Coplug indicator catalogue — definitions, cohorts, policy anchorsReferenceCurrentEvidence-base lines, page 13
    Sources & context

    Where a period is given as "as supplied", the source file did not state a vintage

    Powered by Coplug · Page 14 of 15
    15 / 15

    Methods, data-quality notes and limitations

    Methods, data-quality notes and limitations

    Methods

    Estimated gaps apply benchmark prevalence to the registered population and subtract the recorded register. They size the task; they are not confirmed missed patients.

    Percentage points are the difference between two rates; a relative change is that difference as a share of the starting rate. Register changes are relative, over three years.

    Forecasts to 2030 extend each indicator's current trajectory with no change in case-finding or service model: a baseline to act against, not a prediction.

    Core20 is the most deprived 20% nationally (IMD quintile 1). Practice shares are not additive to the PCN figure. Ethnic minority is 100% minus White. Local-authority averages are unweighted.

    Sources & context

    Estimates size the task; they are not confirmed missed patients

    Powered by Coplug · Page 15 of 15